Literature DB >> 7523742

Total parenteral nutrition decreases luminal mucous gel and increases permeability of small intestine.

Y Iiboshi1, R Nezu, M Kennedy, M Fujii, M Wasa, M Fukuzawa, S Kamata, Y Takagi, A Okada.   

Abstract

The distribution of fluorescein isothiocyanate dextran 70,000 (FITC-dextran) and mucous gel across the lumen of small intestine was observed as an investigation into the role of mucous gel on permeability in total parenteral nutrition (TPN). Thirty-two rats were randomly divided into two groups fed with either TPN or oral rat food. On day 4 or 7, FITC-dextran (750 mg/kg body weight) was given through the gastroduodenal tube. After 1 hour, blood samples were taken by aortic puncture to analyze plasma FITC-dextran by fluorescence spectrometry. Samples of small intestine with luminal contents were frozen and sectioned in a cryostat for fluorescence microscopy; the same sections were placed in a 0.2% celloidin solution for 3 minutes to preserve mucous gel and stained by periodic acid-Schiff reaction for light microscopy. The plasma level of FITC-dextran after 1 hour of this marker injection showed a significant increase (p < .01) in the TPN group compared with the rat food group on days 4 and 7. Morphologic findings on days 4 and 7 were similar in both the jejunum and ileum: The mucous gel filled the spaces between villi and FITC-dextran centered in the lumen in the rat food group, whereas the mucous gel decreased and FITC-dextran filled the spaces between villi in the TPN group. FITC-dextran and mucous gel showed complementary distributions in both groups. These data suggest that TPN decreases luminal mucous gel and increases permeability of small intestine in rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523742     DOI: 10.1177/014860719401800412

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  9 in total

Review 1.  Specific topics and complications of parenteral nutrition.

Authors:  Eduardo E Montalvo-Jave; José L Zarraga; Michael G Sarr
Journal:  Langenbecks Arch Surg       Date:  2007-01-13       Impact factor: 3.445

2.  Cysteinyl-glycine reduces mucosal proinflammatory cytokine response to fMLP in a parenterally-fed piglet model.

Authors:  Matthew G Nosworthy; Janet A Brunton
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

3.  Effects of endotoxin on intestinal hemodynamics, glutamine metabolism, and function.

Authors:  S M Haque; K Chen; N Usui; Y Iiboshi; H Okuyama; A Masunari; R Nezu; Y Takagi; A Okada
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Role of bacterial adherence and the mucus barrier on bacterial translocation: effects of protein malnutrition and endotoxin in rats.

Authors:  M Katayama; D Xu; R D Specian; E A Deitch
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

5.  Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats.

Authors:  J M Mariadason; A Catto-Smith; P R Gibson
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

6.  Morphological changes of cell proliferation and apoptosis in rat jejunal mucosa at different ages.

Authors:  Li Wang; Jian Li; Qing Li; Jian Zhang; Xiang-Lin Duan
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Alanyl-glutamine dipeptide-supplemented parenteral nutrition improves intestinal metabolism and prevents increased permeability in rats.

Authors:  S M Haque; K Chen; N Usui; Y Iiboshi; H Okuyama; A Masunari; L Cui; R Nezu; Y Takagi; A Okada
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

8.  Total parenteral nutrition causes circumferential intestinal atrophy, remodeling of the intestinal wall, and redistribution of eosinophils in the rat gastrointestinal tract.

Authors:  Mikael Ekelund; Elin Kristensson; Mats Ekelund; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.487

9.  Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs.

Authors:  Flore Dossou-Yovo; Godefroy Mamadou; Imar Djibrine Soudy; Nicolas Limas-Nzouzi; Joe Miantezila; Jehan-François Desjeux; Bruno Eto
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.